News Detail
New Delhi, 11 July 2023: Soon, pholcodine-based cough syrups and cold-flu medicines will come with a warning, News18 has learnt. The Indian drug regulatory agency is seeking an expert opinion on the possibility of withdrawing the products from the market, similar to ......
View Details
View Details
Source : DrugsControl Media Services
pholcodine-based cough syrups
World Health Organization (WHO)
DCGI
life-threatening allergic reactions
Australia’s Therapeutic Goods Administration (TGA)
United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)
Malaysia’s National Pharmaceutical Regulatory Agency (NPRA)
perioperative anaphylactic reactions to neuromuscular blocking agents (NMBAs)
Related News
- Trial of Offences must be conducted by a Court of Sessions, there is no bar on a Magistrate taking cognizance of such offences: Jammu and Kashmir and Ladakh HC (14-03-2025)
- Dr Reddy’s recalls Levetiracetam Sodium Chloride Injection in US market (14-03-2025)
- Himachal: 1471 drugs samples failed quality tests in past two years: Minister in Assembly (14-03-2025)
- Licensing delays pushing medical device makers abroad: Parliament panel (14-03-2025)
- Four Smugglers Apprehended for Illicit Drug Sales; 2,930 Tablets Confiscated (14-03-2025)
- 2 antibiotic classes banned for use in animal rearing (13-03-2025)
- DoP organises workshop on PRIP Scheme (13-03-2025)
- Centre and States Prepare to Combat Narcotic Drug Abuse, May Require Barcodes on Packaging (13-03-2025)
- Large consignment of cough syrup recovered before Holi in Madhubani (13-03-2025)
- Poly Medicure gets MDR certification complying EU regulation for 54 products (13-03-2025)